15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering BeiGene, Ltd, 12 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $367.00 to $451.00, so the covering firms are broadly aligned. The average target of $407.75 sits 23% above the current $330.53. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 12 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.71 next quarter toward $9.68 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Strong Buy
Strong Buy00%
Buy12100%
Hold00%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to BeiGene, Ltd.
As of Jul, 12 of 12 firms rate ONC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ONC EPS & revenue forecast
EPS · NEXT QUARTER
$1.71
Range $1.01 – $2.74 · 12 analysts · +57% YoY
Next period, 12 analysts expect BeiGene, Ltd. to earn $1.71 a share (range $1.01 – $2.74), versus $1.09 a year earlier. Full-year consensus is $6.47, growing to $9.68 the year after.
REVENUE · NEXT QUARTER
$1.7B
Range $1.6B – $1.8B · 12 analysts · +18% YoY
Revenue is expected to reach $1.7B (range $1.6B – $1.8B), +18.5% year-over-year. Full-year consensus is $6.5B, rising to $7.5B next year.
Top analysts covering BeiGene, Ltd.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ONC.
#1
Michael Schmidt
Guggenheim · Rank #1
Buy
$420.00+27.1% to target
Overall win rate
55%
+ Follow
#2
Jessica Fye
JP Morgan · Rank #64
Buy
$425.00+28.6% to target
Overall win rate
52%
+ Follow
#3
Leonid Timashev
RBC Capital · Rank #69
Buy
$451.00+36.4% to target
Overall win rate
42%
+ Follow
#4
Yigal Nochomovitz
Citigroup · Rank #131
Buy
$453.00+37.1% to target
Overall win rate
43%
+ Follow
#5
Reni J. Benjamin
JMP Securities · Rank #290
Buy
$396.00+19.8% to target
Overall win rate
33%
+ Follow
ONC stock forecast FAQ
What is ONC's average 12-month price target?+
The 7 analysts with a live target average $407.75 for BeiGene, Ltd. over the next 12 months, ranging from a $451.00 high to a $367.00 low.
Is ONC stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 12 analyst ratings, 12 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ONC?+
The Street-high target is $451.00 (RBC Capital), and the Street-low is $367.00. The average of all 7 active targets is $407.75.
How many Wall Street analysts cover ONC?+
12 analysts have an active rating on BeiGene, Ltd., and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ONC?+
Among analysts who currently cover ONC, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #1). Their current call is Buy with a $420.00 target.
What is BeiGene, Ltd.'s projected EPS for next quarter?+
The consensus estimate is $1.71 per share (range $1.01 – $2.74) across 12 analysts. Full-year EPS is projected at $6.47, rising to $9.68 the following year.
How much revenue is BeiGene, Ltd. expected to report next quarter?+
Consensus revenue is $1.7B (range $1.6B – $1.8B). Full-year revenue is projected at $6.5B, growing to $7.5B next year.
Have analysts been upgrading or downgrading ONC lately?+
As of Jul, 12 of 12 firms rate ONC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ONC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
